Learning Center
veINS Track: Don’t Wait for a Mandate for PIVC Infection Surveillance
Recorded On: 06/06/2022
Hospitals have been collecting data on central line associated complications, most notably central line associated bloodstream infections (CLABSI) for many years; however, many do not include PIVC infection surveillance in their scope. Although not yet mandated in the United States at the federal level, clinicians are encouraged to review strategies for collecting and reporting this data to help drive progress in improving safety across all vascular access and infusion activities to enhance vessel health and preservation. In this session, we will review the current literature on PIVC-related infections and complications, discuss strategies for conducting surveillance, and explain how to use of the data to improve patient outcomes.
Learning Objectives: At the conclusion of this session, learners will be able to:
· Describe the current literature on PIVC-related infections and other complications
· Discuss strategies for conducting surveillance on PIVC infections
· Explain how to use the surveillance data to advocate for your patients
Michelle DeVries, MPH, CIC, VA-BC, CPHQ, FAPIC
Michelle DeVries has been involved in infection prevention and hospital epidemiology for 30 years, spanning community, university, and federal health care facilities as well as postacute care settings. She is passionate about raising awareness around vascular access device complications and devotes her time to education on this topic with an emphasis on data collection and analysis. She was a reviewer for the 2016 and 2021 INS Infusion Therapy Standards of Practice and is now serving on the committee as an author for the 2024 Standards. She is a senior adjunct research fellow with the Alliance for Vascular Access Teaching and Research (AVATAR), a past director-at-large with Vascular Access Certification Corporation (VACC), and the president of the Association for Vascular Access (AVA) for 2024.